Skip to Main Content

Author Details

Artem Sokolov
Harvard Medical School
2006
30
18
PMIDPaper TitleJournal TitlePublished Year
36945543Matrix and analysis metadata standards (MAMS) to facilitate harmonization and reproducibility of single-cell data.bioRxiv2023
37602225Paired evaluation of machine-learning models characterizes effects of confounders and outliers.Patterns (N Y)2023
37602216Erratum: Paired evaluation of machine-learning models characterizes effects of confounders and outliers.Patterns (N Y)2023
36945543Matrix and analysis metadata standards (MAMS) to facilitate harmonization and reproducibility of single-cell data.bioRxiv2023
37547011Addressing persistent challenges in digital image analysis of cancerous tissues.bioRxiv2023
37547011Addressing persistent challenges in digital image analysis of cancerous tissues.bioRxiv2023
37602225Paired evaluation of machine-learning models characterizes effects of confounders and outliers.Patterns (N Y)2023
37602216Erratum: Paired evaluation of machine-learning models characterizes effects of confounders and outliers.Patterns (N Y)2023
34824477MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging.Nat Methods2022
36084643Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements.Cell Rep Med2022
35923923Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.Ther Adv Med Oncol2022
36496454Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia.Nat Commun2022
34864359A community-based approach to image analysis of cells, tissues and tumors.Comput Med Imaging Graph2022
34824477MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging.Nat Methods2022
36496454Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia.Nat Commun2022
35923923Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.Ther Adv Med Oncol2022
36084643Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements.Cell Rep Med2022
34864359A community-based approach to image analysis of cells, tissues and tumors.Comput Med Imaging Graph2022
34469743Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis.Cell Syst2021
33589615Machine learning identifies candidates for drug repurposing in Alzheimer's disease.Nat Commun2021
33560371A serum-based DNA methylation assay provides accurate detection of glioma.Neuro Oncol2021
34469743Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis.Cell Syst2021
33589615Machine learning identifies candidates for drug repurposing in Alzheimer's disease.Nat Commun2021
33560371A serum-based DNA methylation assay provides accurate detection of glioma.Neuro Oncol2021
31514138Facetto: Combining Unsupervised and Supervised Learning for Hierarchical Phenotype Analysis in Multi-Channel Image Data.IEEE Trans Vis Comput Graph2020
31514138Facetto: Combining Unsupervised and Supervised Learning for Hierarchical Phenotype Analysis in Multi-Channel Image Data.IEEE Trans Vis Comput Graph2020
31848351Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer.Sci Data2019
31848351Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer.Sci Data2019
29625051Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.Cell2018
29985747Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.J Clin Oncol2018
29625051Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.Cell2018
29642018A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.Cell Rep2018
29985747Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.J Clin Oncol2018
29642018A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.Cell Rep2018
29211761Prophetic Granger Causality to infer gene regulatory networks.PLoS One2017
28988802A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines.Cell Syst2017
29211761Prophetic Granger Causality to infer gene regulatory networks.PLoS One2017
28988802A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines.Cell Syst2017
27050099N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.Cancer Cell2016
27050099N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.Cancer Cell2016
26960204Pathway-Based Genomics Prediction using Generalized Elastic Net.PLoS Comput Biol2016
26776204ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES.Pac Symp Biocomput2016
26901648Inferring causal molecular networks: empirical assessment through a community-based effort.Nat Methods2016
26776204ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES.Pac Symp Biocomput2016
26960204Pathway-Based Genomics Prediction using Generalized Elastic Net.PLoS Comput Biol2016
26901648Inferring causal molecular networks: empirical assessment through a community-based effort.Nat Methods2016
26460041A basal stem cell signature identifies aggressive prostate cancer phenotypes.Proc Natl Acad Sci U S A2015
26460041A basal stem cell signature identifies aggressive prostate cancer phenotypes.Proc Natl Acad Sci U S A2015
24952901Assessing the clinical utility of cancer genomic and proteomic data across tumor types.Nat Biotechnol2014
24952901Assessing the clinical utility of cancer genomic and proteomic data across tumor types.Nat Biotechnol2014
  • 1 - 50 of 60

Recommended Authors

Jake Crawford
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2018
Number of shared co-authors 1
James Zou
Stanford University
Career Start Year 2016
Number of shared co-authors 0
Mehmet Eren Ahsen
Gies College of Business, University of Illinois at Urbana-Champaign.
Career Start Year 2015
Number of shared co-authors 10
Gregory P Way
Broad Institute of MIT and Harvard
Career Start Year 2015
Number of shared co-authors 10
Anna Goldenberg
SickKids Research Institute
Career Start Year 2011
Number of shared co-authors 20
Kun-Hsing Yu
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 0
Kahn Rhrissorrakrai
T.J. Watson Research Center
Career Start Year 2008
Number of shared co-authors 11
Stephen R Piccolo
Brigham Young University
Career Start Year 2008
Number of shared co-authors 10
Justin Guinney
University of Washington
Career Start Year 2006
Number of shared co-authors 36
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 25
Marco Chierici
Fondazione Bruno Kessler
Career Start Year 2006
Number of shared co-authors 3
Richard A Moffitt
Stony Brook University, and Stony Brook Cancer Center
Career Start Year 2005
Number of shared co-authors 10
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 3
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 6
Holger Fr??hlich
Bonn-Aachen International Center for IT (B-IT), University of Bonn
Career Start Year 2004
Number of shared co-authors 7
May D Wang
Georgia Institute of Technology
Career Start Year 2003
Number of shared co-authors 3
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2003
Number of shared co-authors 3
Su-In Lee
University of Washington
Career Start Year 2003
Number of shared co-authors 2
Giuseppe Jurman
Data Science for Health Research Unit, Bruno Kessler Foundation
Career Start Year 2003
Number of shared co-authors 7
J??rg Rahnenf??hrer
TU Dortmund University
Career Start Year 2002
Number of shared co-authors 3
Assaf Gottlieb
Center for Precision Health, University of Texas Health Science Center at Houston
Career Start Year 2002
Number of shared co-authors 1
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 0
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 9
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 2
Igor Jurisica
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 2
Cesare Furlanello
Bruno Kessler Foundation
Career Start Year 1996
Number of shared co-authors 5
Giorgio Valentini
Universita degli Studi di Milano
Career Start Year 1995
Number of shared co-authors 50
Yuval Kluger
Yale University School of Medicine
Career Start Year 1984
Number of shared co-authors 1
Donald Geman
Johns Hopkins University
Career Start Year 1984
Number of shared co-authors 3
Rainer Spang
University of Regensburg
Career Start Year 1969
Number of shared co-authors 0

Collaborators

Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 11
Kiley Graim
University of Florida.
Co-authored papers 6
Peter K Sorger
Co-authored papers 6
Evan O Paull
Columbia University Irving Medical Center
Co-authored papers 5
Daniel E Carlin
University of California San Diego
Co-authored papers 4
Clarence Yapp
Co-authored papers 3
Laila M Poisson
Co-authored papers 3
Robert Baertsch
Center for Biomolecular Science and Engineering, University of California
Co-authored papers 3
Christopher K Wong
University of California
Co-authored papers 3
Adrian Bivol
University of California
Co-authored papers 3
Asa Ben-Hur
Colorado State University
Co-authored papers 3
Houtan Noushmehr
Henry Ford Hospital
Co-authored papers 3
Owen N Witte
University of California los angeles
Co-authored papers 3
Vladislav Uzunangelov
University of California
Co-authored papers 3
Jeremy L Muhlich
Co-authored papers 3
Tathiane M Malta
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo
Co-authored papers 3
Yulia Newton
University of California, Santa Cruz Genomics Institute
Co-authored papers 3
Christopher Funk
University of Colorado School of Medicine
Co-authored papers 2
Bradley T Hyman
Massachusetts General Hospital
Co-authored papers 2
Maciej Wiznerowicz
Co-authored papers 2
Yuanfang Guan
University of Michigan ann arbor
Co-authored papers 2
Thais S Sabedot
Co-authored papers 2
Thea Norman
Bill & Melinda Gates Foundation
Co-authored papers 2
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 2
Allison L Creason
Oregon Health and Science University
Co-authored papers 2
Adam A Margolin
Icahn School of Medicine
Co-authored papers 2
Tom Mikkelsen
Ontario Brain Institute
Co-authored papers 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Gustavo Stolovitzky
IBM T.J. Watson Research Center
Co-authored papers 2
Jia-Ren Lin
Co-authored papers 2
Release 1.2